PDS Biotechnology (PDSB) Tops Q3 EPS by 10c

PDS Biotechnology (NASDAQ: PDSB) reported Q3 EPS of ($0.35), $0.10 better than the analyst estimate of ($0.45).

For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Redburn upgrades Southwest, stays bullish on Delta and United
• DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2